Want to see SE:VICO full AI Analyst Report?
Vicore Pharma Holding AB (VICO) Income Statement
Vicore Pharma Holding AB Income Statement
Last quarter (Q2 2026), Vicore Pharma Holding AB's total revenue was $2.21M, an increase of 26.75% from the same quarter last year. In Q2, Vicore Pharma Holding AB's net income was $-142.84M. See Vicore Pharma Holding AB’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 3.82M | $ 109.35M | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 3.82M | $ 109.35M | $ -3.42M | $ -3.61M | $ -3.60M | |
| $ 458.26M | $ 303.54M | $ 321.51M | $ 287.49M | $ 293.42M | |
| Depreciation and Amortization | $ 0.00 | $ 2.24M | $ 3.42M | $ 3.61M | $ 3.60M |
| $ -477.41M | $ -166.64M | $ -317.47M | $ -286.20M | $ -289.82M | |
| $ -454.44M | $ -194.19M | $ -321.51M | $ -290.73M | $ -294.82M | |
| $ -23.03M | $ 25.30M | $ 10.18M | $ 1.92M | $ -1.92M | |
| $ -477.47M | $ -168.89M | $ -311.33M | $ -288.81M | $ -296.74M | |
| $ -477.47M | $ -168.63M | $ -310.94M | $ -288.42M | $ -296.48M | |
| Per Share Metrics | |||||
| Basic EPS | $ -1.99 | $ -0.75 | $ -3.22 | $ -3.99 | $ -4.25 |
| Diluted EPS | $ -1.99 | $ -0.75 | $ -3.22 | $ -3.99 | $ -4.25 |
| Weighted Average Shares Outstanding | 239.88M | 225.32M | 96.56M | 72.21M | 69.68M |
| Weighted Average Shares Outstanding (Diluted) | 239.88M | 225.32M | 96.56M | 72.21M | 69.68M |
Currency in SEK